PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page
FDA Approves First Treatment for Episodic Cluster Headache that Reduces the Frequency of Attacks

FDA Approves First Treatment for Episodic Cluster Headache that Reduces the Frequency of Attacks

by PEPID Newsroom | Jun 4, 2019 | Alerts

Emgality (gacanezumab-gnlm) solution has been FDA approved for treatment of episodic cluster headache in adults, the first of its kind. Emgality was approved in 2018 to prevent migraines in adults, and now has shown to reduce the frequency of cluster headache attaches...

Recent Posts

  • Sepsis in the Emergency Department: Recognition and the First Hours
  • Opioid Use Disorder in the Emergency Department: Buprenorphine Initiation, Naloxone Distribution, and the Warm Handoff on International Overdose Awareness Day
  • Dementia in the Emergency Department: Recognizing Delirium, Anticholinergic Burden, and the “Acting Different” Presentation
  • Heat-Related Illness in the Emergency Department: Recognition, Cooling, and the High-Risk Patient
  • EMS Week in Practice: Strengthening the Prehospital-to-ED Continuum for Better Patient Outcomes

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved